Keywords: positive, ph, ii, cenes, morphine, variant, uk

Positive Ph II for CeNeS morphine variant

Article | 30 January 2001

Print This

UK company CeNeS has reported positive Phase II trial results with M6G,a natural metabolite of morphine, in patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in